Form 4: Greenwich LifeSciences CEO and CFO Disposes of Shares
SEC Form 4 Filing
Snehal Patel, CEO and CFO of Greenwich LifeSciences, disposed of 174,825 shares of common stock at a price of $14.3 per share on June 13, 2024.
Summary
- On June 13, 2024, Snehal Patel, the CEO and CFO of Greenwich LifeSciences, disposed of 174,825 shares of the company's common stock.
- The transaction was executed at a price of $14.3 per share.
- Following the transaction, Patel directly owns 5,525,602 shares of Greenwich LifeSciences.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The disposal of shares by an executive could be interpreted negatively, but without further context, it's difficult to assess the true impact.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of the stock disposal transaction. |
| 06/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.